Target intelligence / Profile preview

Polycomb group RING finger protein 3 (PCGF3)

Target
PCGF3
Molecular classification
Polycomb group protein, Transcription factor, Histone modification, Chromatin modifier, E3 ubiquitin ligase
01

Overview

Polycomb group RING finger protein 3 (PCGF3) is a protein-coding gene that encodes a core subunit of non-canonical Polycomb repressive complex 1 (PRC1)-like complexes. These multi-subunit complexes regulate gene expression via chromatin remodeling and epigenetic histone modification, notably monoubiquitination of histone H2A at lysine 119 (H2AK119ub1). PCGF3 plays important roles in the maintenance of transcriptionally repressive states for target genes during development, including X chromosome inactivation in females. Beyond its canonical function as a transcriptional repressor, recent evidence indicates that PCGF3 (along with PCGF5) also acts as a transcriptional activator in embryonic stem cells, collaborating with the pluripotency factor Tex10 and co-activator p300 to regulate genes involved in mesoderm differentiation. Mutations in PCGF3 have been associated with Shukla-Vernon Syndrome and autism spectrum disorders, and dysregulation of PRC1 components is implicated in various cancers. There are currently no direct pharmacologic agents targeting PCGF3, nor are specific biomarkers or safety concerns documented for its inhibition or modulation.

Other names
Polycomb group RING finger protein 3PCGF3RNF3RNF3AFLJ36550DONG1MGC40413RING finger protein 3Aring finger protein 3
02

Mechanism of action

Not applicable; no drugs directly reported as targeting PCGF3; mechanistically, PCGF3 regulates gene expression via chromatin modification and protein-protein interactions

03

Biological functions

Epigenetic gene repressionChromatin remodelingHistone H2A monoubiquitination (particularly at Lys119)Regulation of X chromosome inactivationTranscriptional activation (in specific ES cell contexts)Cell differentiationPluripotency maintenance
04

Disease associations

CancerAutism spectrum disorderShukla-Vernon SyndromeDevelopmental disorders
05

Safety considerations

Not reportedas a developmental and epigenetic regulator, off-target effects or disruption may theoretically impact stem cell differentiation and development

Beyond the preview

Go deeper on Polycomb group RING finger protein 3 (PCGF3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polycomb group RING finger protein 3 (PCGF3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call